Retevmo (Selpercatinib) Capsules Uses

The medicine Retevmo contains Selpercatinib, a kinase inhibitor used in the treatment of patients who have metastatic RET fusion-positive non-small cell lung cancer (NSCLC) and thyroid cancer (namely RET-Mutant Medullary Thyroid Cancer and RET Fusion-Positive Thyroid Cancer). Retevmo capsules are supplied in 40 mg and 80 mg for oral administration. 

Non-Small Cell Lung Cancer

The two major kinds of lung cancer namely; small-cell lung cancer and non-small cell lung cancer (NSCLC). NSCLC (Non-small cell lung cancer) begins when healthy cells in the lung change and grow out of control, forming a mass called a tumor, a lesion, or a nodule. The tumor can begin anywhere in the lung and can be cancerous or benign. When a cancer-causing lung tumor grows, it may shed cancerous cells. Such cells can be carried away in blood or float away in the lymph fluid surrounding lung tissue. Lymph flows through tubes called lymphatic vessels that drain into collecting stations called lymph nodes.

The are 3 types of Non-small cell lung cancer:

• Adenocarcinoma
• Squamous cell carcinoma
• Large cell carcinoma

Healthcare professionals recommend using Retevmo 40 mg and 80 mg in treating patients with metastatic RET fusion-positive non-small cell lung cancer. 

Thyroid Cancer

Thyroid cancer develops in the thyroid. It is a butterfly-shaped gland at the base of the neck. The thyroid gland produces hormones that regulate your metabolism. Hormones released by the thyroid also help control your body temperature, blood pressure and heart rate. 

Thyroid cancer is classified into types based on the kinds of cells found in the tumor. The type is determined when a tissue sample from your cancer is examined under a microscope. The type of thyroid cancer is considered in determining your treatment and prognosis.

The types of thyroid cancer are:

• Papillary
• Follicular
• Medullary
• Anaplastic

Healthcare professionals use Retevmo 80 mg and 40 mg to treat patients with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy and advanced or metastatic RET fusion-positive thyroid cancer require systemic therapy and who are radioactive iodine-refractory. 

Cost of Retevmo

Retevmo price in India is economical, and one can purchase this medicine from certified generic medicine suppliers. To know more about this medicine, one can write to us at info@indianpharmanetwork.in and call 18008891064.